Displaying items by tag: school of medicine

Live HealthSmart Alabama is expanding its footprint throughout the Birmingham area and will extend its model beyond Birmingham to other Alabama communities.
Monoclonal antibody infusion is effective, but UAB doctors say getting the COVID-19 vaccine is the best way to prevent someone from being hospitalized because of COVID-19.
Some 70 percent of unvaccinated pregnant women currently in UAB’s ICUs are on ventilators.

UAB’s Jeanne Marrazzo, M.D., explains the importance of getting vaccinated after having COVID, which vaccine to get and when to get it. 

The largest such survey ever conducted, led by Stefan Kertesz, M.D., shows that weather, rents and personal factors contribute to unsheltered homelessness.
The second in a series of panel discussions will provide up-to-date information on COVID-19 from UAB experts.

In this arteriolar niche, breast cancer stem cells and arteriolar endothelial cells cross-talk using a well-known signaling pathway. Targeting this pathway may offer therapeutic potential.

Studies conducted in America and around the world definitively show that masks are an effective tool in reducing the rate of injection of COVID-19.

“These people are the sickest of the sick.” Hear from one of the nurses helping COVID patients inside UAB Hospital.
The drug Vismodegib, tested in a breast cancer model, is an inhibitor of hedgehog signaling, a form of cell communication manipulated by the tumor microenvironment.

UAB will partner with the Alabama Department of Public Health, Alabama State Department of Education and local school districts to conduct individualized COVID-19 testing plans. The testing is free, voluntary and safe.

Adaptive radiation therapy allows for more precise treatment by fine-tuning the treatment regimen based on up-to-date imaging.
UAB’s House Calls program is bringing COVID-19 vaccines to homebound patients and their eligible caregivers who live within 30-40 miles from UAB.
Jorge de la Torre, M.D., professor and director of the UAB Division of Plastic Surgery, will serve a one-year term as president of the Southeastern Society of Plastic and Reconstructive Surgery.
UAB researchers found that death due to cardiovascular causes in the Southeastern U.S. is 16 percent higher than in the rest of the country, and an estimated 101,953 additional deaths need to be prevented by 2025 to bridge this gap.
The histone methyltransferase DOT1L — the potential target — is overexpressed in ovarian cancer, and high levels of expression correlate with reduced progression-free and overall survival.
Six graduate students in the Academic Medical Center of the 21st Century scholarship program will network with medical professionals, train with top research doctors and receive research funding from the UAB School of Medicine. 
Page 40 of 167